Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.

Renal failure - 1 Jan 2007

Arikan Hakki, Koc Mehmet, Sari Hakan, Tuglular Serhan, Ozener Cetin, Akoglu Emel

Abstract excerpt

BACKGROUND: Apolipoprotein-E (ApoE) gene polymorphism has an important role in lipoprotein metabolism and could participate in the development of cardiovascular diseases (CVD). Plasminogen activator inhibitor-1 (PAI-1) is also regarded as a risk factor for CVD. The aim of the present study is to further investigate the possible link(s) between ApoE gene polymorphism and plasma PAI-1 antigen and serum lipid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoproteins E
Share to Atherosclerosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Kidney Failure, Chronic

Share to Lipids

Share to Peritoneal Dialysis

Share to Plasminogen Activator Inhibitor 1

Share to Renal Dialysis

Source

Identifiers

PMID: 17763167
DOI: 10.1080/08860220701460129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.PMID 17763167Read ↗

The effects of serum apolipoprotein E genetic variants and concentration on serum lipid parameters in haemodialysis patients.Semantic proximity Read ↗

The influence of serum apolipoprotein E concentration and polymorphism on serum lipid parameters in hemodialysis patients.Semantic proximity Read ↗

Apolipoprotein E phenotypes in hemodialysis patients.Semantic proximity Read ↗

The association between serum ApoE genetic polymorphism and serum lipid level in hemodialysis patients.Semantic proximity Read ↗

Association of apoE gene polymorphisms with lipid metabolism in renal diseases.Semantic proximity Read ↗

Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients.Semantic proximity Read ↗

Apolipoprotein E polymorphism and renal disease.Semantic proximity Read ↗

Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM.Semantic proximity Read ↗

Apolipoprotein E polymorphism in 385 patients on renal replacement therapy in Sweden.Semantic proximity Read ↗

The Association between Apolipoprotein E Genotypes and Serum Malondialdehyde Level with End-Stage Renal Disease.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy.Semantic proximity Read ↗

Effect of apolipoprotein e polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.